What is this medicine?
FULVESTRANT (ful VES trant) blocks the effects of estrogen. It is used to treat breast cancer.
How should I use this medicine?
This medicine is for injection into a muscle. It is usually given by a health care professional in a hospital or clinic setting.
Talk to your pediatrician regarding the use of this medicine in children. Special care may be needed.
What side effects may I notice from receiving this medicine?
Side effects that you should report to your doctor or health care professional as soon as possible:
allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue
feeling faint or lightheaded, falls
pain, tingling, numbness, or weakness in the legs
signs and symptoms of infection like fever or chills; cough; flu-like symptoms; sore throat
Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome):
pain at site where injected
What may interact with this medicine?
medicines that treat or prevent blood clots like warfarin, enoxaparin, and dalteparin
What if I miss a dose?
It is important not to miss your dose. Call your doctor or health care professional if you are unable to keep an appointment.
Where should I keep my medicine?
This drug is given in a hospital or clinic and will not be stored at home.
What should I tell my health care provider before I take this medicine?
They need to know if you have any of these conditions:
low levels of platelets in the blood
an unusual or allergic reaction to fulvestrant, other medicines, foods, dyes, or preservatives
pregnant or trying to get pregnant
What should I watch for while using this medicine?
Your condition will be monitored carefully while you are receiving this medicine. You will need important blood work done while you are taking this medicine.
Do not become pregnant while taking this medicine or for at least 1 year after stopping it. Women of child-bearing potential will need to have a negative pregnancy test before starting this medicine. Women should inform their doctor if they wish to become pregnant or think they might be pregnant. There is a potential for serious side effects to an unborn child. Men should inform their doctors if they wish to father a child. This medicine may lower sperm counts. Talk to your health care professional or pharmacist for more information. Do not breast-feed an infant while taking this medicine or for 1 year after the last dose.
Online Medical Reviewer:
Date Last Reviewed: Unavailable
NOTE:This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider. Copyright© 2019 Elsevier
- About Clinical Trials: Information from the National Cancer Institute
- Anastrozole tablets
- Capecitabine tablets
- Cyclophosphamide injection
- Cyclophosphamide tablets or Capsules
- Docetaxel injection
- Doxorubicin injection
- Epirubicin injection
- Estradiol acetate vaginal ring (Femring)
- Estradiol injection
- Estradiol skin patches
- Estradiol tablets
- Estradiol topical emulsion
- Estradiol topical gel
- Estradiol topical spray
- Estradiol vaginal cream
- Estradiol vaginal ring (Estring)
- Estradiol vaginal tablets
- Exemestane tablets
- Fluorouracil, 5-FU injection
- Fluorouracil, 5-FU skin cream or solution
- Goserelin injection
- Ifosfamide injection
- Letrozole tablets
- Megestrol oral suspension
- Megestrol tablets
- Methotrexate injection
- Methotrexate subcutaneous injection
- Methotrexate tablets
- Methyltestosterone tablets or capsules
- Mitoxantrone injection
- Nanoparticle Albumin-Bound Paclitaxel injection
- Paclitaxel injection
- Tamoxifen oral solution
- Tamoxifen oral tablet
- Testolactone tablets
- Testosterone buccal system
- Testosterone injection
- Testosterone skin gel
- Testosterone skin patches
- Testosterone subcutaneous pellets
- Testosterone topical solution
- Thiotepa injection
- Toremifene tablets
- Trastuzumab injection for infusion
- Vinblastine injection
- Vincristine injection